394 related articles for article (PubMed ID: 9372967)
81. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
Park DS; Morris EJ; Bremner R; Keramaris E; Padmanabhan J; Rosenbaum M; Shelanski ML; Geller HM; Greene LA
J Neurosci; 2000 May; 20(9):3104-14. PubMed ID: 10777774
[TBL] [Abstract][Full Text] [Related]
82. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF.
Voit R; Hoffmann M; Grummt I
EMBO J; 1999 Apr; 18(7):1891-9. PubMed ID: 10202152
[TBL] [Abstract][Full Text] [Related]
83. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.
Parry D; Bates S; Mann DJ; Peters G
EMBO J; 1995 Feb; 14(3):503-11. PubMed ID: 7859739
[TBL] [Abstract][Full Text] [Related]
84. Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity.
Reynaud EG; Guillier M; Leibovitch MP; Leibovitch SA
Oncogene; 2000 Feb; 19(9):1147-52. PubMed ID: 10713702
[TBL] [Abstract][Full Text] [Related]
85. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts.
Connell-Crowley L; Elledge SJ; Harper JW
Curr Biol; 1998 Jan; 8(1):65-8. PubMed ID: 9427630
[TBL] [Abstract][Full Text] [Related]
86. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
87. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
88. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth.
Driscoll B; Wu L; Buckley S; Hall FL; Anderson KD; Warburton D
Am J Physiol; 1997 Nov; 273(5):L941-9. PubMed ID: 9374720
[TBL] [Abstract][Full Text] [Related]
89. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation.
Kavurma MM; Khachigian LM
J Biol Chem; 2003 Aug; 278(35):32537-43. PubMed ID: 12796485
[TBL] [Abstract][Full Text] [Related]
90. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation.
Zhang JM; Zhao X; Wei Q; Paterson BM
EMBO J; 1999 Dec; 18(24):6983-93. PubMed ID: 10601020
[TBL] [Abstract][Full Text] [Related]
91. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D; Mahony D; Wills K; Lees E
Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
[TBL] [Abstract][Full Text] [Related]
92. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
93. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
94. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts.
Winston J; Dong F; Pledger WJ
J Biol Chem; 1996 May; 271(19):11253-60. PubMed ID: 8626675
[TBL] [Abstract][Full Text] [Related]
95. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
[TBL] [Abstract][Full Text] [Related]
96. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
[TBL] [Abstract][Full Text] [Related]
97. CDK4/cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and G0 arrest of human fibroblasts.
Gadbois DM; Peterson S; Bradbury EM; Lehnert BE
Exp Cell Res; 1995 Sep; 220(1):220-5. PubMed ID: 7664838
[TBL] [Abstract][Full Text] [Related]
98. p40MO15 associates with a p36 subunit and requires both nuclear translocation and Thr176 phosphorylation to generate cdk-activating kinase activity in Xenopus oocytes.
Labbé JC; Martinez AM; Fesquet D; Capony JP; Darbon JM; Derancourt J; Devault A; Morin N; Cavadore JC; Dorée M
EMBO J; 1994 Nov; 13(21):5155-64. PubMed ID: 7957080
[TBL] [Abstract][Full Text] [Related]
99. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase).
Tassan JP; Schultz SJ; Bartek J; Nigg EA
J Cell Biol; 1994 Oct; 127(2):467-78. PubMed ID: 7929589
[TBL] [Abstract][Full Text] [Related]
100. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.
Fisher RP; Morgan DO
Cell; 1994 Aug; 78(4):713-24. PubMed ID: 8069918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]